InfectoLab Americas uses unique, cutting-edge ELISPOT assay technology to provide information about T-cells activity concerning Borrelia/other pathogen infections and chronic inflammation. The test works by isolating your immune cells and stimulating them with specific antigens purified from the pathogens. Infectolab checks in for multiple sets of antigens independently which will give a greater confidence in the test results. The tests are designed to measures the number of activated T-lymphocytes, which releases the cytokine interferon-γ(effector T-cells) and Interleukin-2(central memory T-cells)against the respective antigen.
This is the most advanced ELISPOT in the market today and provides more information than the traditional two-tier testing and other ELISPOT that are available in the market.